Amicus Therapeutics stock upgraded to Buy as analysts highlight undervalued DMX-200 kidney program and strong Galafold sales growth. Read more here.

K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies ...

Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a ...

Another week of the NFL is in the books. Here we review Week 2, and preview Week 3 which kicks off tonight with Miami at ...